Home » Topics » BioWorld Science

BioWorld Science
RSS

Hemolink enters phase II trials for second indication

Dec. 19, 1997

VIMRx and Baxter form new company focused on cell therapy

Dec. 19, 1997

Nutropin AQ also wins FDA approval

Dec. 19, 1997

Mechanism of exocrine pancreas secretion assessed for herbal medicine

Dec. 19, 1997

S-5920 effective in rat model of acute pancreatitis

Dec. 19, 1997

Positive phase IIa results reported for Cortecs' oral insulin

Dec. 19, 1997

Oral neuraminidase inhibitor advances to phase II/III

Dec. 19, 1997

CholestaGel enters phase III testing

Dec. 19, 1997

MAb for non-Hodgkin's lymphoma now available in U.S.

Dec. 19, 1997

New warnings added to Posicor labeling

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...